Hiroshi Watanabe (Yuka Nakamura)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Venues

Molecular pharmaceutics

Nutrients

Toxins

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Watanabe, Hiroshi Watanabe, Tadashi Imafuku, Issei Fujita, Yuto Ganaha, Toru Takeo, Naomi Nakagata, Hitoshi Maeda, Toru Maruyama
Contribution of the α 1 -Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α 1 -Acid Glycoprotein-Knockout Mice. Molecular pharmaceutics 21 (7) (2024)
Hiroshi Watanabe, Hiroshi Watanabe, Teruya Nakamura, Mami Chirifu, Kana Ishiodori, Tadashi Imafuku, Hitoshi Maeda, Yoshihiro Kobashigawa, Hiroshi Morioka, Toru Maruyama
Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α 1 -Acid Glycoprotein. Molecular pharmaceutics 21 (8) (2024)
Hiroshi Watanabe, Hiroshi Watanabe, Tadashi Imafuku, Issei Fujita, Yuto Ganaha, Toru Takeo, Naomi Nakagata, Hitoshi Maeda, Toru Maruyama
Contribution of the α 1 -Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α 1 -Acid Glycoprotein-Knockout Mice. Molecular pharmaceutics 21 (7) (2024)
Hiroshi Watanabe, Hiroshi Watanabe, Tadashi Imafuku, Issei Fujita, Yuto Ganaha, Toru Takeo, Naomi Nakagata, Hitoshi Maeda, Toru Maruyama
Contribution of the α 1 -Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α 1 -Acid Glycoprotein-Knockout Mice. Molecular pharmaceutics (2024)
Hiroshi Watanabe, Hiroshi Watanabe, Teruya Nakamura, Mami Chirifu, Kana Ishiodori, Tadashi Imafuku, Hitoshi Maeda, Yoshihiro Kobashigawa, Hiroshi Morioka, Toru Maruyama
Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α 1 -Acid Glycoprotein. Molecular pharmaceutics (2024)
Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama
Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins 15 (3) (2023)
Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama
Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins 15 (3) (2023)
Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama
Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins 15 (3) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Taisei Nagasaki, Hitoshi Maeda, Hiroki Yanagisawa, Kento Nishida, Kazuki Kobayashi, Naoki Wada, Isamu Noguchi, Ryotaro Iwakiri, Kazuaki Taguchi, Hiromi Sakai, Junji Saruwatari, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama
Carbon Monoxide-Loaded Red Blood Cell Prevents the Onset of Cisplatin-Induced Acute Kidney Injury. Antioxidants (Basel, Switzerland) 12 (9) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Ryota Murata, Hiroshi Watanabe, Hiroto Nosaki, Kento Nishida, Hitoshi Maeda, Motohiro Nishida, Toru Maruyama
Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action. Pharmaceutics 14 (3) (2022)
Mei Takano, Shota Toda, Hiroshi Watanabe, Rui Fujimura, Kento Nishida, Jing Bi, Yuki Minayoshi, Masako Miyahisa, Hitoshi Maeda, Toru Maruyama
Engineering of a Long-Acting Bone Morphogenetic Protein-7 by Fusion with Albumin for the Treatment of Renal Injury. Pharmaceutics 14 (7) (2022)
Takehiro Nakano, Hiroshi Watanabe, Tadashi Imafuku, Kai Tokumaru, Issei Fujita, Nanaka Arimura, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Masafumi Fukagawa, Toru Maruyama
Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway. Toxins 13 (12) (2021)
Tadashi Imafuku, Hiroshi Watanabe, Kentaro Oniki, Akira Yoshida, Hiromasa Kato, Takehiro Nakano, Kai Tokumaru, Issei Fujita, Nanaka Arimura, Hitoshi Maeda, Yuki Sakamoto, Nozomi Kondo, Ayami Morita, Junji Saruwatari, Motoko Tanaka, Kazutaka Matsushita, Takashi Wada, Masafumi Fukagawa, Masaki Otagiri, Michael L Fitzgerald, Hideaki Jinnouchi, Toru Maruyama
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes. Diabetes care 44 (6) (2021)

Hiroshi Watanabe.css-eqlu8i{font-size:small;padding-left:4px;} (Yuka Nakamura)

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroshi Watanabe (Yuka Nakamura)